PharmaTher Announces Positive Research Results for PharmaPatch™ with N,N-dimethyltryptamine (DMT) and Strategic Investment into Sairiyo Therapeutics

TORONTO, July 18, 2023 (GLOBE NEWSWIRE) — PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a commercial-focused specialty…

Related Keywords

Toronto ,Ontario ,Canada ,New York ,United States ,Canadian ,Gabriel Friedman ,Jake Edmiston ,Daniel Cohen ,Kevin Carmichael ,Fabio Chianelli ,Sprague Dawley ,Paul Mcclory ,Terasaki Institute For Biomedical Innovation ,Pharmather Holdings Ltd ,Pharmadrug Inc ,Postmedia Network Inc ,Pharmather Announces Positive Research Results For Pharmapatch ,National Post ,Neither The Canadian Securities Exchange ,Risk Factors In Company ,Regulation Services Provider ,Company Or Pharmather ,Sairiyo Therapeutics Inc ,Company In Sairiyo ,Pharmather Announces Positive Research Results ,Strategic Investment ,Sairiyo Therapeutics ,Pharmather Holdings ,Terasaki Institute ,Biomedical Innovation ,Victoria Wells ,Financial Times ,Financial Post ,New York Times ,Postmedia Network ,Street East ,Mother Holdings ,Canadian Securities Exchange ,